Spyre Therapeutics (SYRE) return on invested capital (ROIC)

There is no return on invested capital history on record here for Spyre Therapeutics (SYRE). Figures as of 18 Nov 2026, 00:09 UTC, from the company's filings with the SEC and Yahoo Finance.

Figures as of . Older fiscal years come from the company's filings with the SEC, recent ones from Yahoo Finance. Figures, not advice.

Not enough data

A history of return on invested capital needs at least 3 fiscal years; none is on record here for Spyre Therapeutics. Nothing is estimated to fill the gap.

Method

How it is calculated

Return on invested capital is operating income after tax divided by the capital in the business — debt plus equity minus cash — using the company's own tax rate where it is plausible and 21% otherwise, and shown only for the fiscal years in which cash is counted one way.

How to read it

It measures how well the business turns capital into profit whoever supplied it; a figure above the cost of that capital, roughly 8–10%, means growth creates value.

Return on invested capital at health care companies of similar size

Return on invested capital of Spyre Therapeutics and comparable companies
CompanyReturn on invested capitalFiscal year
Vaxcyte PCVX-58.8%2025
Bio-Rad Laboratories BIO2.3%2025
Qiagen QGEN10.0%2025
Insulet PODD19.7%2025

The latest fiscal year on record for each company, in the currency it reports in. Fiscal years end at different times of year.

More on SYRE

Spyre Therapeutics, figure by figure

Spyre Therapeutics (SYRE) overview: price, valuation and scorecardAll health care companies by market value

Spyre Therapeutics return on invested capital (ROIC): questions and answers

How is Spyre Therapeutics's return on invested capital calculated?

Return on invested capital is operating income after tax divided by the capital in the business — debt plus equity minus cash — using the company's own tax rate where it is plausible and 21% otherwise, and shown only for the fiscal years in which cash is counted one way.

Fiscal years are named for the calendar year they end in.

Cite this page

Funkfolio, “Spyre Therapeutics (SYRE) return on invested capital (ROIC)”, data as of 18 November 2026. https://funkfolio.com/stock/SYRE/roic

Underlying data: the company's filings with the SEC and Yahoo Finance.